Overview Pharmacokinetics of Afamelanotide in EPP Patients Status: COMPLETED Trial end date: 2025-01-20 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the concentration of afamelanotide in serum after the administration of afamelanotide in adolescent and adult EPP patients.Phase: PHASE1 Details Lead Sponsor: Clinuvel Europe LimitedTreatments: afamelanotideDrug Implants